ConductScience.org, home

Trial · NCT02460081

Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

NCT02460081, Phase 2, Withdrawn, Celularity Incorporated

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease. Trials, record NCT02460081. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02460081

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
NCT number
NCT02460081
Status
Withdrawn
Phases
Phase 2
Enrollment
0 participants, actual
Lead sponsor
Celularity Incorporated
Conditions
Diabetic Foot, Peripheral Arterial Disease
Interventions
PDA-002, Placebo
First posted
2015-06-02
Last updated
2026-04-29

Source ClinicalTrials.gov

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryAnkle-brachial Index (ABI)Approximately 1 yearThe ankle brachial index is the ratio of the measurement of the blood pressure in the ankle and the arm.
PrimaryTranscutaneous oxygen measurement (TCOM)Approximately 1 yearTranscutaneous oxygen measurement measures the oxygen flow in vessels beneath the skin surface
SecondaryAdverse Events (AEs)Approximatly 1 yearNumber of participants with adverse events
SecondaryUlcer closureApproximatly 1 yearUlcer closure is defined as skin closure of the index ulcer without drainage or need for dressing.
SecondaryComplete wound closure of the index ulcerApproximatly 1 yearComplete wound closure is defined as closure of the index ulcer and retaining wound closure for the subsequent 4 weeks.
SecondaryNumber of ulcersApproximatly 1 yearThe total number of non index ulcers will be collected
SecondarySize of ulcersApproximatly 1 yearThe area of each ulcer will be collected.
Secondary50% closure of the index ulcerApproximatly 1 yearThe time to when the ulcer has closed 50 % will be collected.
SecondaryTime to major amputation (above the ankle) of treated legApproximatly 1 yearThe time to a major amputation (above the ankle) will be collected.
SecondaryWagner Grading ScaleApproximatly 1 yearThe extent of the ulcer will be collected using a standard scale for ulcer assessment.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02460081

GET https://conductscience.org/api/trials/v1/NCT02460081/registered